Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Close this folderOpening ceremony
View the documentMr Xiaoyu Zheng, Director-General, State Drug Administration, China
View the documentDr Yasuhiro Suzuki, Executive Director, Health Technology and Pharmaceuticals, World Health Organization, Geneva, Switzerland
View the documentDr Eng-Kiong Yeoh, Secretary for Health and Welfare, Hong Kong Special Administrative Region, China
View the documentProfessor Alfred Hildebrandt, Chair of the Ninth ICDRA, Germany
View the documentDr Margaret Chan, Chair of the Tenth ICDRA Director of Health, Hong Kong Special Administrative Region, China
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Open this folder and view contentsAntimicrobial resistance - new initiatives
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Open this folder and view contentsHomoeopathy
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Dr Margaret Chan, Chair of the Tenth ICDRA Director of Health, Hong Kong Special Administrative Region, China

I would like to extend a very warm welcome to all of you who have travelled from far and near to this beautiful and dynamic city of Hong Kong SAR, China, to attend the Tenth International Conference of Drug Regulatory Authorities. As mentioned by Professor Hildebrandt, Hong Kong has undergone historical change since 1997. Indeed, on 1 July we will be celebrating the fifth anniversary of Hong Kong’s reunification with her Motherland. This historical reunification has given us a new status, a different perspective and more opportunities to collaborate with fellow professionals from the Member States of the World Health Organization. The holding of the Tenth ICDRA in Hong Kong, China, is one example of such collaboration, and is an opportunity for which we feel very honoured. We would like to thank WHO, Mainland China and fellow drug regulators from different countries for their support.

The Planning Committee has worked diligently with WHO to put together a stimulating programme for this Conference, with emphasis on challenges confronting drug regulators from developed and developing countries alike. Just to give a few examples: the problems of counterfeit drugs, from which no country is immune; the regulatory challenges related to the safety, quality and efficacy of herbal medicines, which are widely used throughout the world but not fully regulated; the issue of access to essential drugs and vaccines, especially in places and by persons where the need is the greatest. We will also discuss the potential and challenges of new technology, biotechnology and e-commerce. Last but not least, we will touch upon the importance, value and impact of harmonization, and the emergence of regional initiatives in this area. I am sure you will find the programme exciting and stimulating, and I look forward to your active participation and frank discussion in the next few days, in the spirit of sharing experiences, promoting collaboration and building consensus on important matters.

Finally, as Chair of the Organizing Committee, I would like to thank WHO, the many individuals and organizations within and outside China, and the SAR authorities for advice and guidance. I would also like to thank my dedicated team of staff who have worked day and night for months to make this conference a reality, and I hope you will enjoy the programme.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014